Clinical trials: Proton Radiotherapy
Bone Metastasis
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
This purpose of this study is to assess the feasibility of FLASH radiotherapy for the palliative treatment of painful bone metastases.
- Trial name
- FAST-01 (NCT04592887)
- Testing
- FLASH Radiotherapy
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Varian, a Siemens Healthineers Company
Tumor, Solid
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
This study is a clinical trial of prospective, single-center, single-arm objective performance criteria. This trial will be conducted with a total of 47 participants enrolled.
- Trial name
- NCT06347731
- Testing
- Proton Radiation Therapy
- Where
- China
- Volunteers
- 47 people
- Sponsor
- Varian, a Siemens Healthineers Company
Solid Tumor, Adult
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
This trial will enroll 47 subjects who will be be treated with the IBA PROTEUS® PLUS Proton Beam radiation Therapy (PBT) medical device.
- Trial name
- NCT07137195
- Testing
- Proton Beam Therapy (PBT)
- Where
- China
- Volunteers
- 47 people
- Sponsor
- Ion Beam Applications
Prostate Cancer Patients Treated by Radiotherapy
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation.
- Trial name
- PT2 (NCT07130682)
- Testing
- Pencil Beam Proton Therapy Treatment Machine
- Where
- Hong Kong
- Volunteers
- 35 people
- Sponsor
- Hong Kong Sanatorium & Hospital
Tumor, Solid
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
This study is prospective, single-center, single-arm objective performance criteria. This trial will be conducted with a total of 47 subjects enrolled.
- Trial name
- NCT06340815
- Testing
- Radiation: Proton Therapy System (ProBeam)
- Where
- China
- Volunteers
- 47 people
- Sponsor
- Varian, a Siemens Healthineers Company
Tumor, Solid
Varian ProBeam Proton Therapy System China Clinical Trial (Hefei)
This study is prospective, two-center, single-arm objective performance criteria. This trial will be conducted in 2 clinical trial sites with a total of 47 subjects enrolled.
- Trial name
- ProBeam (NCT05463055)
- Testing
- Proton Therapy System (ProBeam)
- Where
- China
- Volunteers
- 47 people
- Sponsor
- Varian, a Siemens Healthineers Company
Pancreatic Cancer, Proton Therapy
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer
This is an interventional, single arm, open-label, feasibility trial with gemcitabine and nab-paclitaxel, followed by concomitant proton therapy and capecitabine, followed by re-evaluation and surgery (when feasible) for patients…
- Trial name
- PARC (NCT04894643)
- Testing
- Proton Ions, Nab-PACLitaxel, Gemcitabine
- Where
- 2 sites in Austria
- Volunteers
- 10 people
- Sponsor
- EBG MedAustron GmbH
Bone Metastases in the Thorax
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax
The purpose of this study is to assess toxicities of FLASH radiotherapy treatment and pain relief in subjects with painful thoracic bone metastases.
- Trial name
- FAST-02 (NCT05524064)
- Testing
- FLASH Radiotherapy
- Where
- 2 sites in United States
- Volunteers
- 10 people
- Sponsor
- Varian, a Siemens Healthineers Company
Thoracic Cancer, Pancreatic Cancer Non-resectable
Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System
This study with Chair-Based, Gantry-less Proton System (CBGS) (aka P-CURE Proton Beam Therapy System or Fixed Beam Chair-based Delivery System) is composed of 3 arms, as following: ARM1: Patients with locally recurrent…
- Conditions
- Thoracic Cancer, Pancreatic Cancer Non-resectable, Brain Cancer, Head Cancer
- Trial name
- PPTS (NCT05549414)
- Testing
- Proton Radiation
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- P-Cure
Tumor, Solid
Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou)
This study is prospective, single-center, single-arm objective performance criteria. This trial will be conducted with a total of 47 subjects enrolled.
- Trial name
- NCT06338436
- Testing
- Proton Radiation Therapy System (ProBeam)
- Where
- China
- Volunteers
- 47 people
- Sponsor
- Varian, a Siemens Healthineers Company